ERBB4, which encodes the tyrosine kinase receptor HER4, has varied effects on cancer development, but mutations in this gene have been implicated in several neoplasms, including melanoma, lung carcinoma and stomach carcinoma [48]. This evidence concerns the gene NTRK1 and melanoma.